Tag: Drug
Business & Industry
Lilly Launches New AI Supercomputer for Drug Development
Eli Lilly has launched what it describes as the most powerful AI factory wholly owned and operated by a pharmaceutical company, marking a significant...
Business & Industry
Novo Nordisk and Vivtex Sign Strategic Oral Biologics Deal
Novo Nordisk and Vivtex have formalised a collaboration aimed at advancing next-generation oral biologic therapies targeting obesity, diabetes and related comorbidities.
Under the terms of...
IT & Data Management
Advancing Quality 4.0 Through Centralized Drug Knowledge
Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.
Clinical Trials
Lilly Zepbound-Taltz Combo Gains Ground with Phase 3b Data
Eli Lilly said that its weight-loss medicine Zepbound, when used in combination with psoriasis treatment Taltz, delivered stronger outcomes than Taltz alone in patients...
Business & Industry
FDA Approves Monthly Rybrevant Faspro for EGFR-Mutated NSCLC
Johnson & Johnson (J&J) has obtained approval from the US Food and Drug Administration (FDA) for a revised dosing schedule of Rybrevant Faspro (amivantamab...
Business & Industry
Gilead Secures GH31 Global Rights in $80M Oncology Deal
Gilead Sciences has added another synthetic lethal asset to its oncology portfolio, agreeing to pay $80 million upfront to obtain global rights to a...
Clinical Trials
AstraZeneca Breztri Reports Positive Phase III Trial Results
Results from the Phase III KALOS and LOGOS trials evaluating AstraZeneca Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) in patients with uncontrolled asthma have...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















